Loading
Latest filing published 12 Apr 2018 for Crescita Therapeutics Inc., €6,136.
No signal scores available.
Alain Dugal appears in our data through filings on Crescita Therapeutics Inc. shares, published by SEDI. The record holds 2 filings, for trades running from 24 May 2017 to 6 April 2018.
No open-market sale appears; the market trades are 1 purchase worth €6,136. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2018 alone, the filings show 1 purchase and no sales.
The record was last updated on 12 April 2018 with an open-market purchase (€6,136) in Crescita Therapeutics Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations